Osteoadsorptive bisphosphonate derivatives of fluoroquinolone antibacterials

被引:78
|
作者
Herczegh, P
Buxton, TB
McPherson, JC
Kovács-Kulyassa, A
Brewer, PD
Sztaricskai, F
Stroebel, GG
Plowman, KM
Farcasiu, D
Hartmann, JF
机构
[1] ElizaNor Biopharmaceut Inc, Princeton Jct, NJ 08550 USA
[2] Univ Debrecen, Hungarian Acad Sci, Res Grp Antibiot, Debrecen, Hungary
[3] Eisenhower Army Med Ctr, Dept Clin Invest, Ft Gordon, GA USA
[4] Augusta State Univ, Augusta, GA USA
关键词
D O I
10.1021/jm0105326
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Bisphosphonates conjugated to fluoroquinolone antibacterials through an intermediate carbon had better activity than conjugates lacking the carbon. Virtually all molar-based activity of these esterified bisphosphonate derivatives was identical to that of its parent. De-esterified free-acid forms retained good activity against most Gram-negative bacteria, but not against Gram-positives. A free-acid derivative remained bound to washed bone and completely inhibited Staphylococcus aureus growth. The more potent parent, ciprofloxacin, failed to bind significantly, and bacterial growth occurred.
引用
收藏
页码:2338 / 2341
页数:4
相关论文
共 50 条
  • [31] Syntheses and biological evaluation of new fluoroquinolone antibacterials containing chiral oxiimino pyrrolidine
    Choi, DR
    Shin, JH
    Yang, J
    Yoon, SH
    Jung, YH
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (05) : 1273 - 1277
  • [32] Herbicidal activity of fluoroquinolone derivatives
    Wallace, Michael D.
    Debowski, Aleksandra W.
    Sukhoverkov, Kirill V.
    Mylne, Joshua S.
    Stubbs, Keith A.
    PLANT DIRECT, 2021, 5 (09)
  • [33] An Insight into Patents of Fluoroquinolone Derivatives
    Sharma, Prabodh Chander
    Piplani, Mona
    Rajak, Harish
    LETTERS IN DRUG DESIGN & DISCOVERY, 2015, 12 (10) : 844 - 855
  • [34] A potential new approach for therapy of Helicobacter pylori infection:: Complexation of bismuth with fluoroquinolone antibacterials
    Shaikh, A. R.
    Yadav, M. R.
    Megraud, F.
    HELICOBACTER, 2007, 12 (04) : 403 - 404
  • [35] Gyrase and Topoisomerase IV: Recycling Old Targets for New Antibacterials to Combat Fluoroquinolone Resistance
    Collins, Jessica A.
    Osheroff, Neil
    ACS INFECTIOUS DISEASES, 2024, 10 (04): : 1097 - 1115
  • [36] Adsorption of zwitterionic fluoroquinolone antibacterials to goethite: A charge distribution-multisite complexation model
    Paul, Tias
    Liu, Jinyong
    Machesky, Michael L.
    Strathmann, Timothy J.
    JOURNAL OF COLLOID AND INTERFACE SCIENCE, 2014, 428 : 63 - 72
  • [37] ACTIVE INTESTINAL SECRETION OF THE FLUOROQUINOLONE ANTIBACTERIALS CIPROFLOXACIN, NORFLOXACIN AND PEFLOXACIN - A COMMON SECRETORY PATHWAY
    GRIFFITHS, NM
    HIRST, BH
    SIMMONS, NL
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1994, 269 (02): : 496 - 502
  • [38] Antibacterial Activity of Lipophilic Fluoroquinolone Derivatives
    de Almeida, Camila G.
    Diniz, Claudio G.
    Silva, Vania L.
    Saraiva, Mauricio F.
    Le Hyaric, Mireille
    de Almeida, Mauro V.
    MEDICINAL CHEMISTRY, 2009, 5 (05) : 419 - 421
  • [39] Two fluoroquinolone-bisphosphonate (BP) derivatives show similar binding affinity to calcium phosphate (CP) particles, but have different antibacterial activity
    Buxton, Thomas Brooks
    Runner, Royce R.
    Herczegh, Pal
    McPherson, James C., III
    FASEB JOURNAL, 2008, 22
  • [40] Synthesis and bioactivity of novel bisphosphonate derivatives
    Babu, B. Hari
    Prasad, G. Syam
    Babu, M. F. Stephen
    Haranath, Pallamreddy
    Reddy, S. Hemadri
    Raju, C. Naga
    HETEROCYCLES, 2008, 75 (03) : 611 - 618